Development of the practical usage based technology using the patient customized bioprinting trachea for the regeneration of respiratory tract (trachea)

The Catholic University of Korea, Seoul St. Mary's Hospital0 个研究点目标入组 1 人开始时间: 待定最近更新: 2021年8月30日

适应症

试验速览

暂无简介。

•Patients who requires partial or segmental resection of trachea for the treatment of trachea diseases such as congenital tracheomalacia and traumatic tracheal stenosis, or invading the trachea due to the progression of thyroid cancer.
•Patients who are expected to have functional disorders such as respiratory failure or permanent tracheostomy due to the impossibility of reconstruction of the trachea defect.

•1. Pregnant or lactating women
•2. Those who have had surgery around the thyroid gland or airway before screening
•3. Patients with residual inflammation in the tissues around the thyroid gland or airways at the time of screening
•4. Patients with systemic inflammatory disease at the time of screening
•5. People at high risk of general anesthesia due to liver disease, kidney disease, or heart disease
•6. Patients with sepsis at the time of screening
•7. Patients with a predisposition to bleeding at the time of screening
•8. Those who have had radiation treatment to the head/neck area before screening
•9. Those who have used other clinical trial drugs and clinical trial medical devices within 3 months before screening
•10. Patients with a history of cell therapy
•11. Patients with malignant tumors other than thyroid cancer
•12. Persons judged by other investigators as inappropriate to participate in this clinical trial

发起方